Pulmotect Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $10.3M

  • Investors
  • 11

Pulmotect General Information

Description

Developer of a respiratory therapeutics technology intended to reduce morbidity and mortality in patients at risk of severe respiratory diseases. The company's therapeutics technology stimulates the body's natural defenses to provide broad-spectrum, fast-acting protection against bacterial pneumonia, influenza, fungal pneumonia and Class A bioterror agents, enabling caregivers to prevent and treat respiratory infections.

Contact Information

Website
www.pulmotect.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3900 Essex Lane
  • Suite 575
  • Houston, TX 77027
  • United States
+1 (713)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 3900 Essex Lane
  • Suite 575
  • Houston, TX 77027
  • United States
+1 (713)

Pulmotect Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pulmotect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series C) 09-Sep-2024 $10.3M Completed Generating Revenue
10. Grant 24-Nov-2023 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series B) 10-Mar-2021 Completed Clinical Trials - Phase 2
8. Grant 27-Jan-2021 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series B) 19-Feb-2020 Completed Clinical Trials - Phase 2
6. Grant 15-Apr-2016 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series A) 14-Apr-2016 Completed Clinical Trials - Phase 2
4. Grant 01-Aug-2014 Completed Clinical Trials - Phase 1
3. Grant 09-May-2012 $7.1M Completed Pre-Clinical Trials
2. Grant $2.5M Completed Pre-Clinical Trials
To view Pulmotect’s complete valuation and funding history, request access »

Pulmotect Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Pulmotect’s complete cap table history, request access »

Pulmotect Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Pulmotect Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190269773-A1 Methods and compositions for adaptive immune modulation Active 09-Nov-2016
CA-3043480-A1 Methods and compositions for adaptive immune modulation Pending 09-Nov-2016
AU-2017356673-A1 Methods and compositions for adaptive immune modulation Active 09-Nov-2016
EP-3538218-A2 Methods and compositions for adaptive immune modulation Pending 09-Nov-2016
EP-3538218-A4 Methods and compositions for adaptive immune modulation Pending 09-Nov-2016 A61K39/35
To view Pulmotect’s complete patent history, request access »

Pulmotect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pulmotect Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axil Capital Partners Venture Capital Minority
SkyWalker Property Partners Real Estate Minority
United States Department of Defense Government
Gershon Capital Venture Capital Minority
Jefferson River Capital Family Office Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Pulmotect FAQs

  • When was Pulmotect founded?

    Pulmotect was founded in 2007.

  • Where is Pulmotect headquartered?

    Pulmotect is headquartered in Houston, TX.

  • What is the size of Pulmotect?

    Pulmotect has 7 total employees.

  • What industry is Pulmotect in?

    Pulmotect’s primary industry is Biotechnology.

  • Is Pulmotect a private or public company?

    Pulmotect is a Private company.

  • What is Pulmotect’s current revenue?

    The current revenue for Pulmotect is .

  • How much funding has Pulmotect raised over time?

    Pulmotect has raised $27.5M.

  • Who are Pulmotect’s investors?

    Axil Capital Partners, SkyWalker Property Partners, United States Department of Defense, Gershon Capital, and Jefferson River Capital are 5 of 11 investors who have invested in Pulmotect.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »